Indivior's Opioid Use Disorder Drug Inching Closer To FDA Approval...

The American Depositary Receipts of Indivior plc (INVVY.OB), a global specialty pharmaceutical company focused on developing opioid dependence treatments, are up nearly 38% year-to-date.

from RTT - Biotech http://ift.tt/2BpUuih
via IFTTT